Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-83.04	-2035.48	12004.08
Graham Fair Price	-44.45	1.27	2.29
PEG	500.92	2.96	-0.49
Price/Book	2.65	4.06	3.96
Price/Cash Flow	-61.65	-83.40	217.44
Prices/Earnings	-216.15	-201.94	-63.88
Price/Sales	15.19	30.86	26.79
Price/FCF	-61.65	-83.40	217.44
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	13.83	0.17	0.15
Operating Margin	49.71	-0.03	-0.07
ROA	67.05	< 0.005	-0.01
ROE	-0.02	< 0.005	67.53
ROIC	-0.02	< 0.005	84.30
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	-0.14	-49.45
Dividends QOQ	0.42	7.72	1753.18
EBIT QOQ	-0.02	0.55	2714.30
EPS QOQ	-1.30	0.68	-47.39
FCF QOQ	48.89	-3.67	-92.50
Revenue QOQ	0.24	-0.11	-53.98
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	125.15	141.69	13.22
Days Sales Outstanding (DSO)	121.64	136.91	12.55
Inventory Turnover	0.72	0.64	-11.67
Debt/Capitalization	0.21	0.23	5.67
Quick Ratio	2.20	2.34	6.72
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.87	3.78	-2.52
Cash	1.40	1.29	-7.47
Capex	-0.07	-0.12	-71.83
Free Cash Flow	0.07	-0.18	160.89
Revenue	0.57	0.50	-13.13
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.91	3.14	7.84
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	253.52	-65.85	-74.02
Naive Interpretation	Member

06 - Financial Health · Bad

Rating